Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing by.

ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...

Do not administer by subcutaneous or intravenous routes. Instill intravesically only after dilution. Total time from vial puncture to the completion of the intravesical instillation should not ...

Notably, recurrence free survival was consistent irrespective of tumor size, location, number of tumors and route of administration ... are receiving UGN-103 via intravesical installation once ...

Do not administer by subcutaneous or intravenous routes. Instill intravesically only after dilution. Total time from vial puncture to the completion of the intravesical instillation should not ...

Protara continues to investigate systemic subcutaneous dosing through priming and maintenance combined with intravesical dosing ... unable to meet their choline needs via oral or enteral routes. For ...

Importantly, we should not focus solely on achieving a complete response (CR) at three months but also consider other key factors, including efficacy (both CR and durability of response), treatment ...

J&J is developing a second Taris-derived candidate called TAR-210, an intravesical formulation of J&J's FGFR kinase inhibitor Balversa (erdafitinib), and has predicted that peak sales of the two ...

BCG given via intravesical instillation (delivery to the bladder via a catheter) has been the standard of care for patients with non-muscle invasive bladder cancer (NMIBC) since 1977. BCG induces ...